to disclose information and the vision of the management in order to assist investors to better understand the company's financial status and operation. It also supports the "Good Corporate Governance
made to disclose information and the vision of the management in order to assist investors to better understand the company's financial status and operation. It also supports the "Good Corporate
quarter due mainly to a slump of 52.42% in international sales revenue compared to the same period of the previous year. The reason for this is that the product delivery was delayed after the license was
guidelines for employees to curtail the spread of COVID-19 as well as support our partner and community to help prevent the spread of the virus and support those already affected. Throughout the COVID-19
margin in 2Q2023 was 6.10%, decreased from the gross profit margin of 37.11% in 2Q2022 due to the increase in employee-related costs to support the expansion of the team according to the number and scope
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug
delivery charge. 5. Cost of sales of pipes for the year 2019 was 88.15% of income. The cost per income rate decreased from the year 2018 which was 91.56 percent of income. The major reason was the cost of
relation to the decreasing in sales by 3.42%. Company sell only to some industrial customers, which entered into short-term contract with specific quantities and delivery term (Made to Order). This helps the
sales revenue stood at THB 877.83 million and THB 765.66 million, dropping 12.78% from declining revenue from overseas. This was a result of the delay in product delivery in China after the Company was